"The U.S. Food and Drug Administration is alerting hospitals, health care professionals, and patients of a voluntary recall of all non-expired drug products produced and distributed for sterile use by Abrams Royal Compounding Pharmacy in Dallas, T"...
- Patient Information:
Details with Side Effects
There have been no reports of overdose with KALBITOR (ecallantide injection) . HAE patients have received single doses up to 90 mg intravenously without evidence of dose-related toxicity. No deaths occurred in monkeys that received intravenous or subcutaneous doses up to 25 mg/kg (approximately 22 times the MRHD on an AUC basis).
Do not administer KALBITOR (ecallantide injection) to a patient who has known clinical hypersensitivity to KALBITOR. [see WARNINGS AND PRECAUTIONS].
Last reviewed on RxList: 12/14/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Kalbitor Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.